<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Encounter Summary</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Encounter Summary</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">Robbin L Catrambone</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">June 4, 1965 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Female</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>White</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Not Hispanic or Latino</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Primary Home Address:<br/>1220 WEST PALM AVE<br/>REDLANDS, CA 92373, USA<br/>Effective Date: April 30, 2024 <br/><br/> Previous Address:<br/>431 CHESTNUT AVE<br/>REDLANDS, CA 92373, USA<br/>Effective Date: November 6, 2019 <br/>Expiration Date: April 29, 2024 <br/><br/>Mobile Phone:  +1-951-217-9243<br/>Primary Home Phone:  +1-951-217-9243<br/>Email:  robbincatrambone@gmail.COM<br/>Email:  ROBBIN1965@AOL.COM<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">EPC8Z9N77M5VZ9L 1.2.840.114350.1.13.568.2.7.3.688884.100<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value"> 1.2.840.114350.1.13.568.2.7.8.688883.65470969</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">July 1, 2025, 13:21:14, MST </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Janet O Cantada,  PharmD of Epic Management (Beaver Medical Group)</td></tr><tr><td class="td_header_role_value internal_format"> Work Address:<br/>236 Cajon Street<br/>Redlands, CA 92373, USA<br/><br/>Work Phone:  +1-909-793-3311<br/>Fax:  +1-909-335-4132<br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Chukwuka Akamnonu,  MD of Epic Management (Beaver Medical Group)</td></tr><tr><td class="td_header_role_value internal_format"> Work Address:<br/>245 TERRACINA BLVD STE 209-C<br/>Redlands, CA 92373, USA<br/><br/>Work Phone:  +1-909-793-3311<br/>Fax:  +1-909-335-8710<br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Sunghyun Chung,  MD of Epic Management (Beaver Medical Group)</td></tr><tr><td class="td_header_role_value internal_format"> Work Address:<br/>1600 E Citrus Ave Ste A<br/>Redlands, CA 92374, USA<br/><br/>Work Phone:  +1-909-794-3682<br/>Fax:  +1-909-389-1323<br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Cherine Kim,  MD of Epic Management (Beaver Medical Group)</td></tr><tr><td class="td_header_role_value internal_format"> Work Address:<br/>259 Terracina<br/>Redlands, CA 92373, USA<br/><br/>Work Phone:  +1-909-328-5400<br/>Fax:  +1-909-862-5361<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">Epic - Version 11.3</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">35455579 1.2.840.114350.1.13.568.2.7.3.698084.8</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">Office Visit</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From February 4, 2025, 13:40:00, PST  to February 4, 2025, 14:00:00, PST </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">Optum - Redlands Citrus  Family Med of </td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">Sunghyun Chung of Epic Management (Beaver Medical Group)</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Work Address:<br/>1600 E Citrus Ave Ste A<br/>Redlands, CA 92374, USA<br/><br/>Work Phone:  +1-909-794-3682<br/>Fax:  +1-909-389-1323<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Emergency contact (Unrelated friend)</span></td><td class="td_header_role_value">Shelli Pickens<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Mobile Phone:  +1-909-289-2637<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Legal authenticator</span></td><td class="td_header_role_value"> signed at July 1, 2025, 13:21:14, MST </td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">Epic Management (Beaver Medical Group)</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Work Address:<br/>1615 Orange Tree Lane<br/>REDLANDS, CA 92374, USA<br/><br/><br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Reason for Referral</a></li><li><a href="#id2">Reason for Visit</a></li><li><a href="#id3">Encounter Details</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Last Filed Vital Signs</a></li><li><a href="#id6">Functional Status</a></li><li><a href="#id7">Patient Instructions</a></li><li><a href="#id8">Progress Notes</a></li><li><a href="#id9">Miscellaneous Notes</a></li><li><a href="#id10">Plan of Treatment</a></li><li><a href="#id11">Procedures</a></li><li><a href="#id12">Results</a></li><li><a href="#id13">Visit Diagnoses</a></li><li><a href="#id14">Additional Health Concerns</a></li><li><a href="#id15">Care Teams</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Reason for Referral</a></h3><div><ul><li>Imaging (Routine) - Authorized: <table><colgroup><col span="4" width="25%"/></colgroup><thead><tr><th>Specialty</th><th>Diagnoses / Procedures</th><th>Referred By Contact</th><th>Referred To Contact</th></tr></thead><tbody><tr><td>Radiology</td><td><p>Diagnoses</p><p>Multiple thyroid nodules</p><br/><p>Procedures</p><p>US thyroid</p><p>CHG US SOFT TISSUE HEAD &amp; NECK REAL TIME IMGE DOCM</p></td><td><p>Chung, Sunghyun, MD</p><p>1600 E Citrus Ave Ste A</p><p>Redlands, CA 92374</p><p>Phone: tel:+1-909-794-3682</p><p>fax:+1-909-389-1323</p></td><td><p>OPTUM - XRAY DEPT</p><p>2 W FERN AVE</p><p>REDLANDS, CA 92373-5916</p><p>Phone: tel:+1-909-335-4136</p></td></tr></tbody></table><table><colgroup><col width="13%"/><col width="12%"/><col width="25%"/><col width="13%"/><col width="12%"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Referral ID</th><th>Status</th><th>Reason</th><th>Start Date</th><th>Expiration Date</th><th>Visits Requested</th><th>Visits Authorized</th></tr></thead><tbody><tr><td>5232542</td><td>Authorized</td><td/><td>2/4/2025</td><td>2/4/2026</td><td>1</td><td>1</td></tr></tbody></table><br/><p>Electronically signed by Chung, Sunghyun, MD at 02/04/2025  3:04 PM PST</p></li></ul></div><h3><a name="id2" href="#toc">Reason for Visit</a></h3><div><ul><li><table><colgroup><col width="25%"/><col width="75%"/></colgroup><thead><tr><th>Reason</th><th>Comments</th></tr></thead><tbody><tr ID="rfv3"><td ID="reasonrfv3">Follow-up</td><td ID="rfv3comments">Headaches, thyroid US, MRI of her head</td></tr></tbody></table></li></ul></div><h3><a name="id3" href="#toc">Encounter Details</a></h3><div><table><colgroup><col width="10%"/><col width="15%"/><col span="3" width="25%"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter4" class="xRowNormal"><td>02/04/2025  1:40 PM PST</td><td ID="encounter4type">Office Visit</td><td><p>Optum - Redlands Citrus  Family Med</p><p>1600 E. Citrus Ave #A</p><p>REDLANDS, CA 92374-4802</p><p>909-794-3682</p></td><td><p>Chung, Sunghyun, MD</p><p>1600 E Citrus Ave Ste A</p><p>Redlands, CA 92374</p><p>909-794-3682 (Work)</p><p>909-389-1323 (Fax)</p></td><td><content>Multiple thyroid nodules (Primary Dx); <br/>Tracheal stenosis; <br/>New daily persistent headache; <br/>DM type 2 with diabetic mixed hyperlipidemia (CMS/HCC)  (CMS/HCC); <br/>Type 2 diabetes mellitus with stage 3a chronic kidney disease, with long-term current use of insulin (CMS/HCC); <br/>Uncomplicated opioid dependence (CMS/HCC); <br/>Stage 3a chronic kidney disease (CKD) (CMS/HCC); <br/>Lumbar radiculopathy</content></td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><table ID="sochist15"><colgroup><col span="2" width="25%"/><col width="13%"/><col width="12%"/><col width="25%"/></colgroup><thead><tr><th>Tobacco Use</th><th>Types</th><th>Packs/Day</th><th>Years Used</th><th>Date</th></tr></thead><tbody><tr><td>Smoking Tobacco: Never</td><td/><td ID="sochist15packsperday"/><td/><td/></tr><tr ID="sochist15smokeless" class="xRowAlt"><td>Smokeless Tobacco: Never</td><td/><td/><td/><td/></tr></tbody></table><table><tbody><tr><td ID="sochist15cessation" class="xnoIndent"><span class="xcellHeader">Tobacco Cessation:</span> Counseling Given: Not Answered<br/></td></tr></tbody></table><table ID="sdohassess2"><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>PHQ-2</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess2pair1"><td ID="sdohassess2pair1ques">Patient Health Questionnaire-2 Score</td><td ID="sdohassess2pair1ans">1</td><td>02/04/2025</td></tr></tbody></table><table><colgroup><col width="25%"/><col width="75%"/></colgroup><thead><tr><th>Pregnant</th><th>Comments</th></tr></thead><tbody><tr><td>No</td><td/></tr></tbody></table><table><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Sex and Gender Information</th><th>Value</th><th>Date Recorded</th></tr></thead><tbody><tr ID="BirthSex18"><td>Sex Assigned at Birth</td><td ID="BirthSex18Value">Not on file</td><td/></tr><tr ID="LegalSex19"><td>Legal Sex</td><td ID="LegalSex19Value">Female</td><td>09/05/2019  4:31 PM PDT</td></tr><tr ID="GenderIdentity16"><td>Gender Identity</td><td ID="GenderIdentity16Value">Not on file</td><td/></tr><tr ID="SexualOrientation17"><td>Sexual Orientation</td><td ID="SexualOrientation17Value">Not on file</td><td/></tr></tbody></table>documented as of this encounter</div><h3><a name="id5" href="#toc">Last Filed Vital Signs</a></h3><div><table><colgroup><col span="4" width="25%"/></colgroup><thead><tr><th>Vital Sign</th><th>Reading</th><th>Time Taken</th><th>Comments</th></tr></thead><tbody><tr class="xRowNormal"><td class="xcellHeader">Blood Pressure</td><td><span class="content_span">120</span>/<span class="content_span">69</span></td><td>02/04/2025  1:34 PM PST</td><td/></tr><tr ID="pulse_5809613640" class="xRowAlt"><td class="xcellHeader">Pulse</td><td>63</td><td>02/04/2025  1:34 PM PST</td><td/></tr><tr ID="temp_5809613640" class="xRowNormal"><td class="xcellHeader">Temperature</td><td>35.3 °C (95.6 °F)</td><td>02/04/2025  1:34 PM PST</td><td/></tr><tr ID="resp_5809613640" class="xRowAlt"><td class="xcellHeader">Respiratory Rate</td><td>17</td><td>02/04/2025  1:34 PM PST</td><td/></tr><tr ID="SpO2_" class="xRowNormal"><td class="xcellHeader">Oxygen Saturation</td><td>-</td><td>-</td><td/></tr><tr ID="inhaled_" class="xRowAlt"><td class="xcellHeader">Inhaled Oxygen Concentration</td><td>-</td><td>-</td><td/></tr><tr ID="weight_5809613640" class="xRowNormal"><td class="xcellHeader">Weight</td><td>113 kg (250 lb 3.2 oz)</td><td>02/04/2025  1:34 PM PST</td><td/></tr><tr ID="height_5809613640" class="xRowAlt"><td class="xcellHeader">Height</td><td>163.5 cm (5' 4.37")</td><td>02/04/2025  1:34 PM PST</td><td/></tr><tr ID="bmi_5809613640" class="xRowNormal"><td class="xcellHeader">Body Mass Index</td><td>42.45</td><td>02/04/2025  1:34 PM PST</td><td/></tr></tbody></table>documented in this encounter</div><h3><a name="id6" href="#toc">Functional Status</a></h3><div><ul><li>Over the past 2 weeks, how often have you been bothered by any of the following problems?: <table><colgroup><col width="50%"/><col width="10%"/><col span="2" width="20%"/></colgroup><thead><tr><th>Question</th><th>Answer</th><th>Date of Assessment</th><th>Author</th></tr></thead><tbody><tr ID="disabilityStatus.1570000014"><td>Little interest or pleasure in doing things</td><td>Several days</td><td>02/04/2025  1:33 PM PST</td><td>Smith, Amira, MA</td></tr><tr ID="disabilityStatus.1570000015"><td>Feeling down, depressed, or hopeless</td><td>Not at all</td><td>02/04/2025  1:33 PM PST</td><td>Smith, Amira, MA</td></tr><tr ID="disabilityStatus.1570000016"><td>Patient Health Questionnaire-2 Score</td><td>1</td><td>02/04/2025  1:33 PM PST</td><td>Smith, Amira, MA</td></tr></tbody></table></li><li>If you checked off any problems on this questionnaire so far,: <table><colgroup><col width="50%"/><col width="10%"/><col span="2" width="20%"/></colgroup><thead><tr><th>Question</th><th>Answer</th><th>Date of Assessment</th><th>Author</th></tr></thead><tbody><tr ID="disabilityStatus.1570400187"><td>How difficult have these problems made it for you to do your work, take care of things at home, or get along with other people?</td><td>Extremely difficult</td><td>02/04/2025  1:33 PM PST</td><td>Smith, Amira, MA</td></tr></tbody></table></li></ul>documented as of this encounter</div><h3><a name="id7" href="#toc">Patient Instructions</a></h3><div><ul><li>Patient Instructions: <ul><li><p> <span class="xLabel">Sunghyun Chung, MD - 02/04/2025  1:40 PM PST</span></p><content><span class="xLabel">Formatting of this note is different from the original.</span><br/>Complete these tasks before your next visit. <br/>Labs/Imaging: Please complete repeat blood test and imaging test prior to next visit.<br/><br/>Specialty Visits: ENT, endocrinology<br/><br/>To Do: Continue to take medication prescribed.  Follow-up in 4 to 5 months or sooner as needed.<br/><br/>Orders Placed This Encounter <br/>Procedures <br/> US thyroid <br/> TSH <br/> T4, free <br/> T3, free <br/> BMG CUSTOM DRUG SCREEN PANEL <br/>  </content><br/><span class="xLabel">Electronically signed by Sunghyun Chung, MD at 02/04/2025  3:11 PM PST</span><br/><span class="xLabel">Electronically signed by Sunghyun Chung, MD at 02/04/2025  3:11 PM PST</span><br/><br/></li></ul></li></ul>documented in this encounter</div><h3><a name="id8" href="#toc">Progress Notes</a></h3><div><ul><li>Amira Smith, MA - 02/04/2025  1:40 PM PST: <content><content><span class="xLabel">Formatting of this note is different from the original.</span><br/>Accompanied by:  (name and relationship to pt)<br/><br/>Due for Any Care Gaps?<br/>Health Maintenance Due <br/>Topic Date Due <br/> Mammogram  12/11/2020 <br/> Influenza Vaccine (1) 10/01/2024 <br/> <br/><br/>Results<br/>Any labs done:  No<br/>Any Imaging Done: No<br/><br/>Any Specialty Visits since last visit with PCP? No<br/>Check Specialty Referrals, was pt seen and do we have the notes? <br/>Any Upcoming Specialty Appointments? <br/>Future Appointments <br/>Date Time Provider Department Center <br/>2/4/2025  1:40 PM Sunghyun Chung, MD RADVA FAM MD RLBA <br/> <br/><br/> <br/>Any recent UCC/ER/Hospital visits since your last visit with your PCP?  No<br/>Do you need any refills? No<br/>Any New Vaccinations Received since last visit? No<br/>Is there any paperwork you need to provider to fill out at the appointment? No<br/><br/>Any new problems/changes to medical history since last visit? Yes hair loss, fatigue, brittle nails<br/>Any new surguries since last visit? No<br/><br/>Do you check your blood pressure at home? No<br/>Patient diabetic? Yes<br/>- if yes, offer foot exam 4</content><br/><span class="xLabel">Electronically signed by Amira Smith, MA at 02/04/2025  1:32 PM PST</span><br/></content></li><li>Sunghyun Chung, MD - 02/04/2025  1:40 PM PST: <content><content><span class="xLabel">Formatting of this note is different from the original.</span><br/>Patient ID: Robbin L Catrambone is a 59 y.o. female.<br/><br/>Chief Complaint <br/>Patient presents with <br/> Follow-up <br/>  Headaches, thyroid US, MRI of her head <br/><br/>Subjective <br/><br/>HPI<br/>See assessment and plan for problem-based HPI.<br/><br/> <br/><br/>Objective <br/><br/>Visit Vitals<br/>BP 120/69 (BP Location: Right arm, Patient Position: Sitting, BP Cuff Size: Adult) <br/>Pulse 63 <br/>Temp 35.3 °C (95.6 °F) (Temporal) <br/>Resp 17 <br/>Ht 1.635 m (5' 4.37") <br/>Wt 113 kg (250 lb 3.2 oz) <br/>BMI 42.45 kg/m² <br/>OB Status Postmenopausal <br/>Smoking Status Never <br/>BSA 2.27 m² <br/><br/>Physical Exam<br/>Constitutional:  <br/>   Appearance: Normal appearance. <br/>   Comments: Patient is sweating <br/>Cardiovascular: <br/>   Rate and Rhythm: Normal rate and regular rhythm. <br/>   Pulses: Normal pulses. <br/>Pulmonary: <br/>   Effort: Pulmonary effort is normal. <br/>   Breath sounds: Normal breath sounds. <br/>Abdominal: <br/>   General: Abdomen is flat. Bowel sounds are normal. <br/>   Palpations: Abdomen is soft. <br/>Musculoskeletal:    <br/>   General: Normal range of motion. <br/>   Comments: Using cane for ambulation <br/>Skin:<br/>   General: Skin is warm and dry. <br/>Neurological: <br/>   General: No focal deficit present. <br/>   Mental Status: She is alert and oriented to person, place, and time. <br/><br/> <br/><br/>Assessment and Plan:<br/><br/>1. Multiple thyroid nodules (Primary)<br/>Overview:<br/>Thyroid ultrasound from March 2024 showed Multiple cystic and solid nodules noted in both lobes of the thyroid with the largest one measuring up to 1.9 cm.<br/>Recommended follow-up in 1 year<br/>Assessment &amp; Plan:<br/>Order thyroid ultrasound<br/>Order thyroid panel<br/>Follow-up with results<br/>Orders:<br/>-     TSH; Future<br/>-     T4, free; Future<br/>-     T3, free; Future<br/>-     Ultrasound thyroid; Future; Expected date: 02/04/2025<br/>2. Tracheal stenosis<br/>Assessment &amp; Plan:<br/>Patient states she had tracheal scarring status post removal and now it is chronic back<br/>Patient feels little more feeling of choking compared to last visit<br/>Referral to ENT as patient has seen Dr. Umeda previously for the same issue<br/>3. New daily persistent headache<br/>Assessment &amp; Plan:<br/>New onset headache started about 1 to 2 weeks ago<br/>Patient states it might be related to congestion secondary to allergy<br/>Patient has mostly consistent headache and frontal area<br/>Trial of sinus rinse and Flonase<br/>Precautions regarding Flonase given including epistaxis<br/>Follow-up on next visit<br/>Orders:<br/>-     Fluticasone Propionate; Administer 2 sprays into each nostril 1 (one) time each day for 10 days. Shake gently. Before first use, prime pump. After use, clean tip and replace cap.  Dispense: 15.8 g; Refill: 0<br/>4. DM type 2 with diabetic mixed hyperlipidemia (CMS/HCC)  (CMS/HCC)<br/>Overview:<br/>Currently on atorvastatin 80 mg daily and omega-3 1 g twice daily<br/>CHOLESTEROL, TOTAL <br/>Date Value Ref Range Status <br/>12/10/2024 226 (H) &lt;200 mg/dL Final <br/><br/>LDL-CHOLESTEROL <br/>Date Value Ref Range Status <br/>12/10/2024 SEE NOTE mg/dL (calc) Final <br/>  Comment: <br/>   <br/>LDL cholesterol not calculated. Triglyceride levels<br/>greater than 400 mg/dL invalidate calculated LDL results.<br/> <br/>Reference range: &lt;100<br/> <br/>Desirable range &lt;100 mg/dL for primary prevention;  <br/>&lt;70 mg/dL for patients with CHD or diabetic patients <br/>with &gt; or = 2 CHD risk factors.<br/> <br/>LDL-C is now calculated using the Martin-Hopkins <br/>calculation, which is a validated novel method providing <br/>better accuracy than the Friedewald equation in the <br/>estimation of LDL-C. <br/>Martin SS et al. JAMA. 2013;310(19): 2061-2068 <br/>(http://education.QuestDiagnostics.com/faq/FAQ164)<br/> <br/><br/>HDL CHOLESTEROL <br/>Date Value Ref Range Status <br/>12/10/2024 48 (L) &gt; OR = 50 mg/dL Final <br/><br/>TRIGLYCERIDES <br/>Date Value Ref Range Status <br/>12/10/2024 554 (H) &lt;150 mg/dL Final <br/>  Comment: <br/>   <br/>If a non-fasting specimen was collected, consider<br/>repeat triglyceride testing on a fasting specimen<br/>if clinically indicated. <br/>Jacobson et al. J. of Clin. Lipidol. 2015;9:129-169.<br/> <br/> <br/>There is increased risk of pancreatitis when the <br/>triglyceride concentration is very high <br/>(&gt; or = 500 mg/dL, especially if &gt; or = 1000 mg/dL). <br/>Jacobson et al. J. of Clin. Lipidol. 2015;9:129-169.<br/> <br/> <br/><br/>Assessment &amp; Plan:<br/>Continue current medication<br/>Repeat lipid panel in 3 to 6 months<br/>5. Type 2 diabetes mellitus with stage 3a chronic kidney disease, with long-term current use of insulin (CMS/HCC)<br/>Overview:<br/>Metformin-liver damage. <br/>Januvia-tongue swelling.<br/>Glipizide-right abd/rib swelling. <br/>Jardiance 25mg-yeast infection. <br/><br/>Crestor 40 mg a day<br/>Insulin Levemir 12 units nightly<br/>Insulin lispro 40 units in the morning, 25 units before lunch, and 25 units every evening.<br/><br/>GFR 52 ON 11/15/22<br/>GFR 54 ON 9/8/22<br/>GFR 53 8/9/22<br/>GFR 47 ON 8/5/22<br/>GFR 50 ON 5/20/22<br/>EGFR <br/>Date Value Ref Range Status <br/>04/30/2024 60 &gt; OR = 60 mL/min/1.73m2 Final <br/><br/>6. Uncomplicated opioid dependence (CMS/HCC)<br/>Overview:<br/>Currently on Percocet 10-325 mg every 6 hours as needed, Flexeril, Cymbalta, pregabalin, prednisone<br/>Last CURES review (usually last refill):  1/30/2025  7:41 PM<br/>Her MME/day:  60 MME/Day<br/>Naloxone:  Yes<br/>Last visit with PCP: 09/05/24<br/>Last UDS: No results found for requested labs within last 365 days. <br/>Pain Agreement: On file, 09/07/2023<br/><br/>Assessment &amp; Plan:<br/>Renew pain contract<br/>Order UDS<br/>Continue to monitor<br/>Orders:<br/>-     BMG CUSTOM DRUG SCREEN PANEL; Future<br/>7. Stage 3a chronic kidney disease (CKD) (CMS/HCC)<br/>Overview:<br/>EGFR <br/>Date Value Ref Range Status <br/>12/10/2024 61 &gt; OR = 60 mL/min/1.73m2 Final <br/>09/05/2024 51 (L) &gt; OR = 60 mL/min/1.73m2 Final <br/>04/30/2024 60 &gt; OR = 60 mL/min/1.73m2 Final <br/><br/>CREATININE <br/>Date Value Ref Range Status <br/>12/10/2024 1.06 (H) 0.50 - 1.03 mg/dL Final <br/>09/05/2024 1.22 (H) 0.50 - 1.03 mg/dL Final <br/>04/30/2024 1.07 (H) 0.50 - 1.03 mg/dL Final <br/><br/>Assessment &amp; Plan:<br/>Stable<br/>Continue to monitor<br/>8. Lumbar radiculopathy<br/>Overview:<br/>Currently taking Percocet 10-325 mg every 6 hours as needed, Flexeril 10 mg<br/>Last CURES review (usually last refill):  1/30/2025  7:41 PM<br/>Her MME/day:  60 MME/Day<br/>Naloxone:  Yes<br/>Last visit with PCP: 09/05/24<br/>Last UDS: No results found for requested labs within last 365 days. <br/>Pain Agreement: On file, 09/07/2023<br/><br/>Assessment &amp; Plan:<br/>Had seen spine specialist, pain specialist, physical therapy<br/>Pain is controlled by Percocet, Flexeril, pregabalin, Cymbalta<br/>Continue to monitor<br/><br/>The following portions of the patient's chart were reviewed in this encounter and updated as appropriate:  Tobacco | Allergies | Meds | Problems | Med Hx | Surg Hx | OB Status | <br/>Fam Hx | <br/> <br/><br/>Discussed with patient:<br/>Call us if symptoms persist.  <br/>Go to ER if symptoms worsen or new symptoms develop.<br/>Patient reports understanding and agrees with treatment plan. <br/><br/>Sunghyun Chung, MD <br/><br/>ATTESTATION: This medical document was created using an electronic medical record system (Dragon). Although this document has been carefully reviewed, there may still be some phonetic and typographical errors due to imperfections of the software program. These errors do not reflect any compromise in the patient's medical care. </content><br/><span class="xLabel">Electronically signed by Sunghyun Chung, MD at 02/04/2025  3:12 PM PST</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id9" href="#toc">Miscellaneous Notes</a></h3><div><ul><li>Assessment &amp; Plan Note - Sunghyun Chung, MD - 02/04/2025  3:10 PM PST: <content><span class="Bold">Associated Problem(s): Tracheal stenosis</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>Patient states she had tracheal scarring status post removal and now it is chronic back<br/>Patient feels little more feeling of choking compared to last visit<br/>Referral to ENT as patient has seen Dr. Umeda previously for the same issue</content><br/><span class="xLabel">Electronically signed by Sunghyun Chung, MD at 02/04/2025  3:10 PM PST</span><br/></content></li><li>Assessment &amp; Plan Note - Sunghyun Chung, MD - 02/04/2025  3:09 PM PST: <content><span class="Bold">Associated Problem(s): Stage 3a chronic kidney disease (CKD) (CMS/HCC)</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>Stable<br/>Continue to monitor</content><br/><span class="xLabel">Electronically signed by Sunghyun Chung, MD at 02/04/2025  3:09 PM PST</span><br/></content></li><li>Assessment &amp; Plan Note - Sunghyun Chung, MD - 02/04/2025  3:09 PM PST: <content><span class="Bold">Associated Problem(s): Multiple thyroid nodules</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>Order thyroid ultrasound<br/>Order thyroid panel<br/>Follow-up with results</content><br/><span class="xLabel">Electronically signed by Sunghyun Chung, MD at 02/04/2025  3:09 PM PST</span><br/></content></li><li>Assessment &amp; Plan Note - Sunghyun Chung, MD - 02/04/2025  3:08 PM PST: <content><span class="Bold">Associated Problem(s): Lumbar radiculopathy</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>Had seen spine specialist, pain specialist, physical therapy<br/>Pain is controlled by Percocet, Flexeril, pregabalin, Cymbalta<br/>Continue to monitor</content><br/><span class="xLabel">Electronically signed by Sunghyun Chung, MD at 02/04/2025  3:08 PM PST</span><br/></content></li><li>Assessment &amp; Plan Note - Sunghyun Chung, MD - 02/04/2025  3:07 PM PST: <content><span class="Bold">Associated Problem(s): Uncomplicated opioid dependence (CMS/HCC)</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>Renew pain contract<br/>Order UDS<br/>Continue to monitor</content><br/><span class="xLabel">Electronically signed by Sunghyun Chung, MD at 02/04/2025  3:07 PM PST</span><br/></content></li><li>Assessment &amp; Plan Note - Sunghyun Chung, MD - 02/04/2025  3:06 PM PST: <content><span class="Bold">Associated Problem(s): Headache</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>New onset headache started about 1 to 2 weeks ago<br/>Patient states it might be related to congestion secondary to allergy<br/>Patient has mostly consistent headache and frontal area<br/>Trial of sinus rinse and Flonase<br/>Precautions regarding Flonase given including epistaxis<br/>Follow-up on next visit</content><br/><span class="xLabel">Electronically signed by Sunghyun Chung, MD at 02/04/2025  3:06 PM PST</span><br/></content></li><li>Assessment &amp; Plan Note - Sunghyun Chung, MD - 02/04/2025  3:05 PM PST: <content><span class="Bold">Associated Problem(s): DM type 2 with diabetic mixed hyperlipidemia (CMS/HCC)  (CMS/HCC)</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>Continue current medication<br/>Repeat lipid panel in 3 to 6 months</content><br/><span class="xLabel">Electronically signed by Sunghyun Chung, MD at 02/04/2025  3:05 PM PST</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id10" href="#toc">Plan of Treatment</a></h3><div><table><span style="font-weight:bold; ">Pending Results</span><colgroup><col width="25%"/><col width="15%"/><col width="10%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Name</th><th>Type</th><th>Priority</th><th>Associated Diagnoses</th><th>Date/Time</th></tr></thead><tbody><tr ID="procedure48"><td><span class="content_span">BMG CUSTOM DRUG SCREEN PANEL</span></td><td>Lab</td><td>Routine</td><td><p>Uncomplicated opioid dependence (CMS/HCC)</p></td><td>02/04/2025  3:02 PM PST</td></tr></tbody></table><table><span style="font-weight:bold; ">Scheduled Orders</span><colgroup><col width="25%"/><col width="15%"/><col width="10%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Name</th><th>Type</th><th>Priority</th><th>Associated Diagnoses</th><th>Order Schedule</th></tr></thead><tbody><tr ID="procedure49"><td><span class="content_span">TSH</span></td><td>Lab</td><td>Routine</td><td><p>Multiple thyroid nodules</p></td><td ID="procedure49schedule">1 Occurrences starting 02/04/2025 until 02/04/2026</td></tr><tr ID="procedure50"><td><span class="content_span">T4, free</span></td><td>Lab</td><td>Routine</td><td><p>Multiple thyroid nodules</p></td><td ID="procedure50schedule">1 Occurrences starting 02/04/2025 until 02/04/2026</td></tr><tr ID="procedure51"><td><span class="content_span">T3, free</span></td><td>Lab</td><td>Routine</td><td><p>Multiple thyroid nodules</p></td><td ID="procedure51schedule">1 Occurrences starting 02/04/2025 until 02/04/2026</td></tr><tr ID="procedure52"><td><span class="content_span">BMG CUSTOM DRUG SCREEN PANEL</span></td><td>Lab</td><td>Routine</td><td><p>Uncomplicated opioid dependence (CMS/HCC)</p></td><td ID="procedure52schedule">1 Occurrences starting 02/04/2025 until 02/04/2026</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id11" href="#toc">Procedures</a></h3><div><table><colgroup><col width="25%"/><col width="10%"/><col width="15%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Procedure Name</th><th>Priority</th><th>Date/Time</th><th>Associated Diagnosis</th><th>Comments</th></tr></thead><tbody><tr ID="procedure60" class="xRowNormal"><td><span class="content_span">DRUG MONITORING, PANEL 6 WITH CONFIRMATION, URINE</span></td><td>Routine</td><td>02/04/2025  3:02 PM PST</td><td/><td><p>Results for this procedure are in the <span class="xLink2-Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728">results section</span>.</p></td></tr><tr ID="procedure59" class="xRowAlt"><td><span class="content_span">DRUG MONITOR, BUP, W/CONF,W/NALOXONE,URINE</span></td><td>Routine</td><td>02/04/2025  3:02 PM PST</td><td/><td><p>Results for this procedure are in the <span class="xLink2-Result.1.2.840.114350.1.13.568.2.7.2.798268.39878729">results section</span>.</p></td></tr><tr ID="procedure58" class="xRowNormal"><td><span class="content_span">DRUG MONITORING, TAPENTADOL, QN, URINE</span></td><td>Routine</td><td>02/04/2025  3:02 PM PST</td><td/><td><p>Results for this procedure are in the <span class="xLink2-Result.1.2.840.114350.1.13.568.2.7.2.798268.39878731">results section</span>.</p></td></tr><tr ID="procedure57" class="xRowAlt"><td><span class="content_span">DRUG MONITORING, FENTANYL, QN, URINE</span></td><td>Routine</td><td>02/04/2025  3:02 PM PST</td><td/><td><p>Results for this procedure are in the <span class="xLink2-Result.1.2.840.114350.1.13.568.2.7.2.798268.39878730">results section</span>.</p></td></tr><tr ID="procedure56" class="xRowNormal"><td><span class="content_span">DRUG MONITOR TRAMADOL QN URINE</span></td><td>Routine</td><td>02/04/2025  3:02 PM PST</td><td/><td><p>Results for this procedure are in the <span class="xLink2-Result.1.2.840.114350.1.13.568.2.7.2.798268.39878732">results section</span>.</p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id12" href="#toc">Results</a></h3><div><ul><li>US thyroid (02/11/2025  2:39 PM PST): <table><colgroup><col span="2" width="25%"/><col width="50%"/></colgroup><thead><tr><th>Anatomical Region</th><th>Laterality</th><th>Modality</th></tr></thead><tbody><tr><td>Head and Neck</td><td/><td>Ultrasound</td></tr></tbody></table><table><colgroup><col span="5" width="20%"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39954150.Specimen"/><td/><td/><td>02/11/2025  2:13 PM PST</td><td/></tr></tbody></table><table><thead><tr><th>Impressions</th></tr></thead><tbody><tr><td class="xpre"><p>02/14/2025 12:08 PM PST</p><p><span class="content_span">TI-RADS risk category 2</span><br/><span class="content_span"> </span><br/><span class="content_span">ACR TI-RADS recommendations</span><br/><span class="content_span">TR5 (?7 points) - FNA if ? 1cm, follow-up if 0.5 - 0.9 cm every year for 5 years</span><br/><span class="content_span">TR4 (4-6 points) - FNA if ? 1.5cm, follow-up if 1 - 1.4 cm in 1, 2, 3 and 5 years</span><br/><span class="content_span">TR3 (3 points)- FNA if ? 2.5cm, follow-up if 1.5 - 2.4 cm in 1, 3 and 5 years</span><br/><span class="content_span">TR2 (2 points) &amp; TR1 (0 points) - No FNA or follow-up</span><br/><span class="content_span"> </span></p></td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p>02/14/2025 12:08 PM PST</p><p><span class="content_span">PROCEDURE: Ultrasonography of the thyroid gland.</span><br/><span class="content_span"> </span><br/><span class="content_span">CLINICAL HISTORY: Multiple thyroid nodules.</span><br/><span class="content_span"> </span><br/><span class="content_span">TECHNIQUE: Realtime ultrasonography of the thyroid gland is performed. Multiple sonographic images are obtained.</span><br/><span class="content_span"> </span><br/><span class="content_span">COMPARISON: 03/19/2024.</span><br/><span class="content_span"> </span><br/><span class="content_span">FINDINGS: The right lobe of the thyroid gland measures 5.8 x 3 x 2.8 cm and the left lobe measures 5.3 x 2.2 x 2.2 cm. The isthmus measures 0.4 cm.  </span><br/><span class="content_span"> </span><br/><span class="content_span">Nodule #: 1</span><br/><span class="content_span">Size: 1.6 x 1.4 x 1.2 cm</span><br/><span class="content_span">Location: right; upper</span><br/><span class="content_span">Composition: mixed cystic and solid (1)</span><br/><span class="content_span">Echogenicity: cannot determine (1)</span><br/><span class="content_span">Shape: not taller-than-wide (0)</span><br/><span class="content_span">Margins: ill-defined (0)</span><br/><span class="content_span">Echogenic foci: none (0)</span><br/><span class="content_span">ACR TI-RADS total points: 2</span><br/><span class="content_span">ACR TI-RADS risk category: TR2 (2 points) </span><br/><span class="content_span"> </span><br/><span class="content_span">Nodule #: 2</span><br/><span class="content_span">Size: 2.1 x 2.2 x 1.4 cm</span><br/><span class="content_span">Location: right; mid</span><br/><span class="content_span">Composition: mixed cystic and solid (1)</span><br/><span class="content_span">Echogenicity: cannot determine (1)</span><br/><span class="content_span">Shape: not taller-than-wide (0)</span><br/><span class="content_span">Margins: ill-defined (0)</span><br/><span class="content_span">Echogenic foci: none (0)</span><br/><span class="content_span">ACR TI-RADS total points: 2</span><br/><span class="content_span">ACR TI-RADS risk category: TR2 (2 points) </span><br/><span class="content_span"> </span><br/><span class="content_span">Nodule #: 3</span><br/><span class="content_span">Size: 0.7 x 0.6 x 0.5 cm</span><br/><span class="content_span">Location: right; mid</span><br/><span class="content_span">Composition: mixed cystic and solid (1)</span><br/><span class="content_span">Echogenicity: cannot determine (1)</span><br/><span class="content_span">Shape: not taller-than-wide (0)</span><br/><span class="content_span">Margins: ill-defined (0)</span><br/><span class="content_span">Echogenic foci: none (0)</span><br/><span class="content_span">ACR TI-RADS total points: 2</span><br/><span class="content_span">ACR TI-RADS risk category: TR2 (2 points) </span><br/><span class="content_span"> </span><br/><span class="content_span">Nodule #: 4</span><br/><span class="content_span">Size: 2.2 x 1.6 x 1.2 cm</span><br/><span class="content_span">Location: left; mid</span><br/><span class="content_span">Composition: mixed cystic and solid (1)</span><br/><span class="content_span">Echogenicity: cannot determine (1)</span><br/><span class="content_span">Shape: not taller-than-wide (0)</span><br/><span class="content_span">Margins: ill-defined (0)</span><br/><span class="content_span">Echogenic foci: none (0)</span><br/><span class="content_span">ACR TI-RADS total points: 2</span><br/><span class="content_span">ACR TI-RADS risk category: TR2 (2 points) </span><br/><span class="content_span"> </span></p></td></tr></tbody></table><table><thead><tr><th>Procedure Note</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39954150.ProcedureNote90580202" class="xnoIndent"><p>Quan, Albert, MD - 02/14/2025</p><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/><span class="content_span">PROCEDURE: Ultrasonography of the thyroid gland.</span><br/><br/><span class="content_span">CLINICAL HISTORY: Multiple thyroid nodules.</span><br/><br/><span class="content_span">TECHNIQUE: Realtime ultrasonography of the thyroid gland is performed. </span><span class="content_span">Multiple sonographic images are obtained.</span><br/><br/><span class="content_span">COMPARISON: 03/19/2024.</span><br/><br/><span class="content_span">FINDINGS: The right lobe of the thyroid gland measures 5.8 x 3 x 2.8 cm </span><span class="content_span">and the left lobe measures 5.3 x 2.2 x 2.2 cm. The isthmus measures 0.4 </span><span class="content_span">cm.  </span><br/><span class="content_span"> </span><br/><span class="content_span">Nodule #: 1</span><br/><span class="content_span">Size: 1.6 x 1.4 x 1.2 cm</span><br/><span class="content_span">Location: right; upper</span><br/><span class="content_span">Composition: mixed cystic and solid (1)</span><br/><span class="content_span">Echogenicity: cannot determine (1)</span><br/><span class="content_span">Shape: not taller-than-wide (0)</span><br/><span class="content_span">Margins: ill-defined (0)</span><br/><span class="content_span">Echogenic foci: none (0)</span><br/><span class="content_span">ACR TI-RADS total points: 2</span><br/><span class="content_span">ACR TI-RADS risk category: TR2 (2 points) </span><br/><br/><span class="content_span">Nodule #: 2</span><br/><span class="content_span">Size: 2.1 x 2.2 x 1.4 cm</span><br/><span class="content_span">Location: right; mid</span><br/><span class="content_span">Composition: mixed cystic and solid (1)</span><br/><span class="content_span">Echogenicity: cannot determine (1)</span><br/><span class="content_span">Shape: not taller-than-wide (0)</span><br/><span class="content_span">Margins: ill-defined (0)</span><br/><span class="content_span">Echogenic foci: none (0)</span><br/><span class="content_span">ACR TI-RADS total points: 2</span><br/><span class="content_span">ACR TI-RADS risk category: TR2 (2 points) </span><br/><br/><span class="content_span">Nodule #: 3</span><br/><span class="content_span">Size: 0.7 x 0.6 x 0.5 cm</span><br/><span class="content_span">Location: right; mid</span><br/><span class="content_span">Composition: mixed cystic and solid (1)</span><br/><span class="content_span">Echogenicity: cannot determine (1)</span><br/><span class="content_span">Shape: not taller-than-wide (0)</span><br/><span class="content_span">Margins: ill-defined (0)</span><br/><span class="content_span">Echogenic foci: none (0)</span><br/><span class="content_span">ACR TI-RADS total points: 2</span><br/><span class="content_span">ACR TI-RADS risk category: TR2 (2 points) </span><br/><br/><span class="content_span">Nodule #: 4</span><br/><span class="content_span">Size: 2.2 x 1.6 x 1.2 cm</span><br/><span class="content_span">Location: left; mid</span><br/><span class="content_span">Composition: mixed cystic and solid (1)</span><br/><span class="content_span">Echogenicity: cannot determine (1)</span><br/><span class="content_span">Shape: not taller-than-wide (0)</span><br/><span class="content_span">Margins: ill-defined (0)</span><br/><span class="content_span">Echogenic foci: none (0)</span><br/><span class="content_span">ACR TI-RADS total points: 2</span><br/><span class="content_span">ACR TI-RADS risk category: TR2 (2 points) </span><br/><br/><span class="content_span">IMPRESSION:</span><br/><span class="content_span">TI-RADS risk category 2</span><br/><br/><span class="content_span">ACR TI-RADS recommendations</span><br/><span class="content_span">TR5 (?7 points) - FNA if ? 1cm, follow-up if 0.5 - 0.9 cm every year for 5 </span><span class="content_span">years</span><br/><span class="content_span">TR4 (4-6 points) - FNA if ? 1.5cm, follow-up if 1 - 1.4 cm in 1, 2, 3 and </span><span class="content_span">5 years</span><br/><span class="content_span">TR3 (3 points)- FNA if ? 2.5cm, follow-up if 1.5 - 2.4 cm in 1, 3 and 5 </span><span class="content_span">years</span><br/><span class="content_span">TR2 (2 points) &amp; TR1 (0 points) - No FNA or follow-up</span><br/></content><br/></td></tr></tbody></table><table><colgroup><col span="2" width="20%"/><col width="60%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th><th>Result Status</th></tr></thead><tbody><tr><td>Sunghyun Chung MD</td><td>IMG US PROCEDURES</td><td>Final Result</td></tr></tbody></table></li><li>DRUG MONITOR TRAMADOL QN URINE (02/04/2025  3:02 PM PST): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col span="2" width="10%"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878732.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878732.Comp1Name">DESMETHYLTRAMADOL</td><td>NEGATIVE</td><td>&lt;100 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878732.Comp1Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878732.Comp2" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878732.Comp2Name">TRAMADOL</td><td>NEGATIVE</td><td>&lt;100 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878732.Comp2Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878732.Comp3" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878732.Comp3Name">TRAMADOL COMMENTS</td><td><span class="content_span">SEE NOTE</span></td><td/><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878732.Comp3Signature"/></tr><tr class="xRowNormal xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><span class="content_span">See LDT Notes</span></content></td></tr></tbody></table><table><colgroup><col span="5" width="20%"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878732.Specimen"/><td/><td/><td>02/04/2025  3:02 PM PST</td><td>02/05/2025 12:35 AM PST</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p>QUEST - 02/06/2025  4:35 PM PST</p><p><span class="content_span">FASTING: UNKNOWN</span></p></td></tr></tbody></table><table><colgroup><col span="2" width="20%"/><col width="60%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th><th>Result Status</th></tr></thead><tbody><tr><td>Sunghyun Chung MD</td><td>LAB BODY FLUIDS AND STOOLS ORDERABLES</td><td>Final Result</td></tr></tbody></table><table><colgroup><col span="3" width="20%"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878732.PerformingLab"><p>QUEST</p></td><td/><td/><td><p/></td></tr><tr><td><p>Quest Diagnostics-Nichols Valencia</p></td><td><p>8407 Fallbrook Ave, Suite 100</p></td><td><p>West Hills, CA 91304-3226</p></td><td><p/></td></tr></tbody></table></li><li>Tapentadol, Drug Monitoring, Urine (02/04/2025  3:02 PM PST): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col span="2" width="10%"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878731.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878731.Comp1Name">TAPENTADOL</td><td>NEGATIVE</td><td>&lt;50 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878731.Comp1Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878731.Comp2" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878731.Comp2Name">NORTAPENTADOL</td><td>NEGATIVE</td><td>&lt;50 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878731.Comp2Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878731.Comp3" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878731.Comp3Name">TAPENTADOL COMMENTS</td><td><span class="content_span">SEE NOTE</span></td><td/><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878731.Comp3Signature"/></tr><tr class="xRowNormal xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><span class="content_span">See LDT Notes</span></content></td></tr></tbody></table><table><colgroup><col span="5" width="20%"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878731.Specimen"/><td/><td/><td>02/04/2025  3:02 PM PST</td><td>02/05/2025 12:35 AM PST</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p>QUEST - 02/06/2025  4:35 PM PST</p><p><span class="content_span">FASTING: UNKNOWN</span></p></td></tr></tbody></table><table><colgroup><col span="2" width="20%"/><col width="60%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th><th>Result Status</th></tr></thead><tbody><tr><td>Sunghyun Chung MD</td><td>LAB URINE ORDERABLES</td><td>Final Result</td></tr></tbody></table><table><colgroup><col span="3" width="20%"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878731.PerformingLab"><p>QUEST</p></td><td/><td/><td><p/></td></tr><tr><td><p>Quest Diagnostics-Nichols Valencia</p></td><td><p>8407 Fallbrook Ave, Suite 100</p></td><td><p>West Hills, CA 91304-3226</p></td><td><p/></td></tr></tbody></table></li><li>Fentanyl, Drug Monitoring, Urine (02/04/2025  3:02 PM PST): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col span="2" width="10%"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878730.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878730.Comp1Name">FENTANYL</td><td>NEGATIVE</td><td>&lt;0.5 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878730.Comp1Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878730.Comp2" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878730.Comp2Name">NORFENTANYL</td><td>NEGATIVE</td><td>&lt;0.5 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878730.Comp2Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878730.Comp3" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878730.Comp3Name">FENTANYL COMMENTS</td><td><span class="content_span">SEE NOTE</span></td><td/><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878730.Comp3Signature"/></tr><tr class="xRowNormal xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><span class="content_span">See LDT Notes</span></content></td></tr></tbody></table><table><colgroup><col span="5" width="20%"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878730.Specimen"/><td/><td/><td>02/04/2025  3:02 PM PST</td><td>02/05/2025 12:35 AM PST</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p>QUEST - 02/06/2025  4:35 PM PST</p><p><span class="content_span">FASTING: UNKNOWN</span></p></td></tr></tbody></table><table><colgroup><col span="2" width="20%"/><col width="60%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th><th>Result Status</th></tr></thead><tbody><tr><td>Sunghyun Chung MD</td><td>LAB URINE ORDERABLES</td><td>Final Result</td></tr></tbody></table><table><colgroup><col span="3" width="20%"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878730.PerformingLab"><p>QUEST</p></td><td/><td/><td><p/></td></tr><tr><td><p>Quest Diagnostics-Nichols Valencia</p></td><td><p>8407 Fallbrook Ave, Suite 100</p></td><td><p>West Hills, CA 91304-3226</p></td><td><p/></td></tr></tbody></table></li><li>DRUG MONITOR, BUP, W/CONF,W/NALOXONE,URINE (02/04/2025  3:02 PM PST): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col span="2" width="10%"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878729.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878729.Comp1Name">BUPRENORPHINE</td><td>NEGATIVE</td><td>&lt;5 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878729.Comp1Signature"/></tr></tbody></table><table><colgroup><col span="5" width="20%"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878729.Specimen"/><td/><td/><td>02/04/2025  3:02 PM PST</td><td>02/05/2025 12:35 AM PST</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p>QUEST - 02/06/2025  4:35 PM PST</p><p><span class="content_span">FASTING: UNKNOWN</span></p></td></tr></tbody></table><table><colgroup><col span="2" width="20%"/><col width="60%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th><th>Result Status</th></tr></thead><tbody><tr><td>Sunghyun Chung MD</td><td>LAB BLOOD ORDERABLES</td><td>Final Result</td></tr></tbody></table><table><colgroup><col span="3" width="20%"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878729.PerformingLab"><p>QUEST</p></td><td/><td/><td><p/></td></tr><tr><td><p>Quest Diagnostics-Nichols Valencia</p></td><td><p>8407 Fallbrook Ave, Suite 100</p></td><td><p>West Hills, CA 91304-3226</p></td><td><p/></td></tr></tbody></table></li><li>(ABNORMAL) DRUG MONITORING, PANEL 6 WITH CONFIRMATION, URINE (02/04/2025  3:02 PM PST): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col span="2" width="10%"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp1Name">ALCOHOL METABOLITES</td><td>NEGATIVE</td><td>&lt;500 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp1Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp2" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp2Name">AMPHETAMINES</td><td>NEGATIVE</td><td>&lt;500 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp2Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp3" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp3Name">BARBITURATES</td><td>NEGATIVE</td><td>&lt;300 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp3Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp4" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp4Name">BENZODIAZEPINES</td><td>NEGATIVE</td><td>&lt;100 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp4Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp5" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp5Name">COCAINE METABOLITE</td><td>NEGATIVE</td><td>&lt;150 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp5Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp6" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp6Name">6 ACETYLMORPHINE</td><td>NEGATIVE</td><td>&lt;10 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp6Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp7" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp7Name">MARIJUANA METABOLITE</td><td>NEGATIVE</td><td>&lt;20 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp7Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp8" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp8Name">METHADONE METABOLITE</td><td>NEGATIVE</td><td>&lt;100 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp8Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp9" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp9Name">OPIATES</td><td>NEGATIVE CONFIRMED</td><td>&lt;100 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp9Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp10" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp10Name">CODEINE</td><td>NEGATIVE</td><td>&lt;50 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp10Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp11" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp11Name">HYDROCODONE</td><td>NEGATIVE</td><td>&lt;50 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp11Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp12" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp12Name">HYDROMORPHONE</td><td>NEGATIVE</td><td>&lt;50 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp12Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp13" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp13Name">MORPHINE</td><td>NEGATIVE</td><td>&lt;50 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp13Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp14" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp14Name">NORHYDROCODONE</td><td>NEGATIVE</td><td>&lt;50 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp14Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp15" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp15Name">OPIATES COMMENTS</td><td><span class="content_span">SEE NOTE</span></td><td/><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp15Signature"/></tr><tr class="xRowNormal xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><span class="content_span">See LDT Notes</span></content></td></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp16" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp16Name">OXYCODONE</td><td><span class="xflagData">POSITIVE</span><span class="xflagData"> (A)</span></td><td>&lt;100 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp16Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp17" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp17Name">NOROXYCODONE</td><td><span class="xflagData">8,640</span><span class="xflagData"> (H)</span></td><td>&lt;50 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp17Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp18" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp18Name">OXYCODONE</td><td><span class="xflagData">7,691</span><span class="xflagData"> (H)</span></td><td>&lt;50 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp18Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp19" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp19Name">OXYMORPHONE</td><td><span class="xflagData">8,448</span><span class="xflagData"> (H)</span></td><td>&lt;50 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp19Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp20" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp20Name">OXYCODONE COMMENTS</td><td><span class="content_span">SEE NOTE</span></td><td/><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp20Signature"/></tr><tr class="xRowAlt xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><span class="content_span">See Oxycodone Notes, LDT Notes</span></content></td></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp21" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp21Name">PHENCYCLIDINE</td><td>NEGATIVE</td><td>&lt;25 ng/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp21Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp22" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp22Name">CREATININE</td><td>195.9</td><td>&gt; or = 20.0 mg/dL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp22Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp23" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp23Name">PH</td><td>5.3</td><td>4.5 - 9.0</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp23Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp24" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp24Name">OXIDANT</td><td>NEGATIVE</td><td>&lt;200 mcg/mL</td><td/><td/><td>Quest Diagnostics-Nichols Valencia</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp24Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp25" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp25Name">NOTES AND COMMENTS</td><td><span class="content_span">SEE NOTE</span></td><td/><td/><td/><td>Quest Diagnostics-West Hills</td><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Comp25Signature"/></tr><tr class="xRowNormal xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><br/><content class="xpre">This drug testing is for medical treatment only.<br/>Analysis was performed as non-forensic testing and<br/>these results should be used only by healthcare<br/>providers to render diagnosis or treatment, or to<br/>monitor progress of medical conditions.<br/> <br/>Oxycodone Notes:<br/>Oxycodone, Noroxycodone, Oxymorphone detected is <br/>consistent with the use of the drug Oxycodone.<br/> <br/>Oxymorphone detected is consistent with the use of the <br/>drug Oxymorphone.<br/> <br/>Oxymorphone can be a prescribed drug and is also a <br/>metabolite of Oxycodone.<br/> <br/>LDT Notes:<br/>Confirmation tests were developed and their analytical <br/>performance characteristics have been determined by <br/>Quest Diagnostics. It has not been cleared or approved <br/>by the FDA. This assay has been validated pursuant to <br/>the CLIA regulations and is used for clinical purposes.<br/> <br/> <br/>Healthcare Providers needing Interpretation assistance, <br/>please contact us at 1.877.40.RXTOX (1.877.407.9869) <br/>M-F, 8am to 10pm EST<br/> <br/></content></content></td></tr></tbody></table><table><colgroup><col span="5" width="20%"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.Specimen"/><td/><td/><td>02/04/2025  3:02 PM PST</td><td>02/05/2025 12:35 AM PST</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p>QUEST - 02/06/2025  4:35 PM PST</p><p><span class="content_span">FASTING: UNKNOWN</span></p></td></tr></tbody></table><table><colgroup><col span="2" width="20%"/><col width="60%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th><th>Result Status</th></tr></thead><tbody><tr><td>Sunghyun Chung MD</td><td>LAB BLOOD ORDERABLES</td><td>Final Result</td></tr></tbody></table><table><colgroup><col span="3" width="20%"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.568.2.7.2.798268.39878728.PerformingLab"><p>QUEST</p></td><td/><td/><td><p/></td></tr><tr><td><p>Quest Diagnostics-Nichols Valencia</p></td><td><p>8407 Fallbrook Ave, Suite 100</p></td><td><p>West Hills, CA 91304-3226</p></td><td><p/></td></tr><tr><td><p>Quest Diagnostics-West Hills</p></td><td><p>8401 Fallbrook Ave</p></td><td><p>West Hills, CA 91304-3226</p></td><td><p/></td></tr></tbody></table></li></ul>documented in this encounter</div><h3><a name="id13" href="#toc">Visit Diagnoses</a></h3><div><table><colgroup><col width="100%"/></colgroup><thead><tr><th>Diagnosis</th></tr></thead><tbody><tr ID="vdx5" class="xRowNormal"><td><p><span class="content_span">Multiple thyroid nodules</span><span class="content_span"> - Primary</span></p><p>Nontoxic multinodular goiter</p></td></tr><tr ID="vdx6" class="xRowAlt"><td><p><span class="content_span">Tracheal stenosis</span></p><p>Other diseases of trachea and bronchus</p></td></tr><tr ID="vdx7" class="xRowNormal"><td><p><span class="content_span">New daily persistent headache</span></p></td></tr><tr ID="vdx8" class="xRowAlt"><td><p><span class="content_span">DM type 2 with diabetic mixed hyperlipidemia (CMS/HCC)  (CMS/HCC)</span></p></td></tr><tr ID="vdx9" class="xRowNormal"><td><p><span class="content_span">Type 2 diabetes mellitus with stage 3a chronic kidney disease, with long-term current use of insulin (CMS/HCC)</span></p></td></tr><tr ID="vdx10" class="xRowAlt"><td><p><span class="content_span">Uncomplicated opioid dependence (CMS/HCC)</span></p></td></tr><tr ID="vdx11" class="xRowNormal"><td><p><span class="content_span">Stage 3a chronic kidney disease (CKD) (CMS/HCC)</span></p></td></tr><tr ID="vdx12" class="xRowAlt"><td><p><span class="content_span">Lumbar radiculopathy</span></p><p>Thoracic or lumbosacral neuritis or radiculitis, unspecified</p></td></tr><tr ID="vdx63" class="xRowNormal"><td><p><span class="content_span">Multiple thyroid nodules</span></p><p>Nontoxic multinodular goiter</p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id14" href="#toc">Additional Health Concerns</a></h3><div><table><colgroup><col width="50%"/><col span="2" width="12.5%"/><col width="25%"/></colgroup><thead><tr><th>Infection</th><th>Onset Date</th><th>Last Indicated</th><th>Resolved Time</th></tr></thead><tbody><tr><td><span class="content_span">COVID-19 Rule-Out</span></td><td>04/09/2021</td><td>04/09/2021</td><td/></tr></tbody></table><table><colgroup><col span="2" width="50%"/></colgroup><thead><tr><th>Assessment</th><th>Noted Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="assessment1">PHQ-9 Depression Total Score: 1</td><td>02/04/2025  1:33 PM PST</td></tr><tr class="xRowAlt"><td ID="assessment2">A fall risk assessment has been completed for the patient</td><td>04/30/2024  2:41 PM PDT</td></tr><tr class="xRowNormal"><td ID="assessment3">PHQ-2 Depression Total Score: 1</td><td>02/04/2025  1:33 PM PST</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id15" href="#toc">Care Teams</a></h3><div><table ID="ct71"><colgroup><col span="3" width="25%"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Team Member</th><th>Relationship</th><th>Specialty</th><th>Start Date</th><th>End Date</th></tr></thead><tbody><tr class="xRowNormal"><td><p>Chung, Sunghyun, MD</p><p>NPI: 1073181707</p><p>1600 E Citrus Ave Ste A</p><p>Redlands, CA 92374</p><p>909-794-3682 (Work)</p><p>909-389-1323 (Fax)</p></td><td>PCP - General</td><td>Family Medicine</td><td>8/23/24</td><td/></tr><tr class="xRowAlt"><td><p>Cantada, Janet O, PharmD</p><p>NPI: 1083180392</p><p>236 Cajon Street</p><p>Redlands, CA 92373</p><p>909-793-3311 (Work)</p><p>909-335-4132 (Fax)</p></td><td>Pharmacist</td><td>Pharmacy</td><td>6/17/20</td><td/></tr><tr class="xRowNormal"><td><p>Akamnonu, Chukwuka, MD</p><p>NPI: 1225423353</p><p>245 TERRACINA BLVD STE 209-C</p><p>Redlands, CA 92373</p><p>909-793-3311 (Work)</p><p>909-335-8710 (Fax)</p></td><td>Referring Physician</td><td>Endocrinology</td><td>6/6/22</td><td/></tr><tr class="xRowAlt"><td><p>Kim, Cherine, MD</p><p>NPI: 1578943189</p><p>259 Terracina</p><p>Redlands, CA 92373</p><p>909-328-5400 (Work)</p><p>909-862-5361 (Fax)</p></td><td>Referring Physician</td><td>Otolaryngology</td><td>8/29/24</td><td/></tr></tbody></table>documented as of this encounter</div><br/><br/></body></html>